Hay fever season is ramping up, and a fresh wave of allergy relief products is hitting shelves to meet soaring demand. The over-the-counter (OTC) hay fever market reached an all-time high of £197 million in 2024, with experts predicting that seasonal allergies will affect 31.8 million people in the UK by 2030. To address this growing need, Olbas has launched a new Anti Allergy Nasal Spray designed to prevent and relieve hay fever symptoms using a blend of hypertonic saline, soothing aloe vera, and natural essential oils. \n\nWhy Are Nasal Sprays Becoming the Preferred Allergy Treatment? \n\nNasal sprays have emerged as one of the most popular formats for allergy relief, and for good reason. Unlike oral antihistamines that take time to work throughout your system, nasal sprays deliver relief directly where you need it most. The new Olbas formula works in two ways: it creates a protective barrier over the nasal passages to prevent allergens from making contact, and it actively soothes irritation once symptoms develop. This dual-action approach makes it practical for people managing allergies in real-world settings, whether at home or on the go. \n\nThe product is suitable for both adults and children aged six and older, making it accessible to a wide range of hay fever sufferers. Users can apply one spray in each nostril up to three times daily for symptom relief and prevention. \n\nWhat's Driving the Explosive Growth in Allergy Products? \n\nThe surge in hay fever cases reflects broader trends in seasonal allergies. Several factors are contributing to this growth. Rachel Realf, brand manager at Olbas, explained the company's approach: "With seasonal allergies looking to rise, and nasal spray formats proving to be incredibly popular amongst consumers, we wanted to develop a product that brings the trusted relief of Olbas to more customers. Olbas Anti Allergy Nasal Spray is designed to fit seamlessly into everyday life, providing quick and effective relief on the go or at home, whilst keeping noses feeling fresh and comfortable". \n\nThe market data tells a compelling story. The OTC hay fever category hit £197 million in sales value during 2024, signaling that retailers and manufacturers are investing heavily in allergy solutions. With projections showing hay fever cases climbing to 31.8 million people by 2030 in the UK alone, having a robust allergy product range will become essential for retailers, particularly during spring and summer months. \n\nHow to Choose and Use Allergy Nasal Sprays Effectively \n\n \n- Timing: Use nasal sprays preventatively before allergen exposure when possible, not just after symptoms appear, to create a protective barrier against pollen and other allergens. \n- Frequency: Follow the recommended dosage of one spray in each nostril up to three times daily; overuse can reduce effectiveness and may cause irritation. \n- Ingredients: Look for formulas that combine saline solutions with soothing ingredients like aloe vera and natural essential oils for both relief and comfort. \n- Age Appropriateness: Confirm that any nasal spray is suitable for your age group; many products are designed for adults and children six and older. \n \n\nThe new Olbas Anti Allergy Nasal Spray will be available at a recommended retail price of £6.99 for a 20-milliliter bottle, making it an affordable option for managing seasonal allergies. \n\nAs allergy season approaches and cases continue to climb, having effective, accessible relief options becomes increasingly important. The combination of growing demand, rising case numbers, and innovative product formats suggests that nasal sprays will play a central role in how millions of people manage hay fever and other seasonal allergies in the years ahead. "\n}
